Drug
SYHX2011 clinical trials
Also written SYHX2011.
Keep track of what changes. Save the SYHX2011 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2023 (1)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 1
CSPC Ouyi Pharmaceutical Co., Ltd. (2) · Shanghai Chest Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses SYHX2011 is read from its arms, and is right about nine times in ten.
Testing it · 3
- SYHX2011 in Combination With Carboplatin and Enlonstobart as First-Line Therapy for Squamous Non-Small Cell Lung CancerNot yet recruitingPhase 2/3Shanghai Chest HospitalNCT07662811Written as SYHX2011
- A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011Not yet recruitingPhase 2CSPC Ouyi Pharmaceutical Co., Ltd.NCT06354114Written as SYHX2011
- A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)Status unknownPhase 3CSPC Ouyi Pharmaceutical Co., Ltd.NCT05753865Written as SYHX2011